Durable response to treatment of an atypical desmoplastic small round cell tumor with enfortumab-vedotin
This case report is the first documented usage of EV in the management of a desmoplastic small round cell tumor case and gives light to a new potential therapeutic strategy for this rare and aggressive tumor.
Authors
- Seth M. Pollack (ORCID: https://orcid.org/0000-0002-2466-0607)
- Julia Shapiro (ORCID: https://orcid.org/0000-0002-5521-2284)
- Farres Obeidin (ORCID: https://orcid.org/0000-0001-8461-9238)
- John S. Wang (ORCID: https://orcid.org/0000-0002-7191-0437)
- David James VanderWeele (ORCID: https://orcid.org/0000-0003-4576-5034)
- Rusul Al-Marayaty
- Haris Charalambous (ORCID: https://orcid.org/0000-0002-6518-1936)
- Pedro Hermida de Viveiros
- Sarah Orlando
Institutions
- Northwestern University (US)
- Università Campus Bio-Medico (IT)
- Washington Hospital (US)
- MedStar Georgetown University Hospital (US)
- Bank of Cyprus Oncology Center (CY)
- MedStar Health (US)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1007/s00432-025-06102-3
- Citations
- 2
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04